+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
ID05189496

Evaluating Hyperbaric Oxygen Therapy to Prevent Lung Problems After Breast Cancer Radiotherapy and Chemotherapy

Led by Guangdong Provincial People's Hospital · Updated on 2025-02-12

380

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating whether hyperbaric oxygen therapy can reduce the risk of radiation pneumonitis and improve quality of life in breast cancer patients who have undergone radiotherapy. Radiotherapy is an important treatment to increase survival but can cause lung injury and pulmonary fibrosis, affecting patients health. This study aims to assess the safety and long-term survival impact of hyperbaric oxygen treatment in this setting. The study randomly divides 380 breast cancer patients into two groups. One group receives 30 to 40 sessions of hyperbaric oxygen therapy immediately after finishing radiotherapy, while the other group does not receive this treatment. Researchers will compare the incidence of radiation pneumonitis and evaluate symptom severity, safety, and quality of life outcomes between the groups. Participants will be monitored over a one-year period to track the occurrence and severity of radiation pneumonitis using clinical assessments and imaging. Quality of life and long-term survival outcomes will also be evaluated. The study includes regular follow-ups to assess safety and treatment effects, providing important data on whether hyperbaric oxygen therapy can help protect lung tissue after radiotherapy in breast cancer patients.

CONDITIONS

Brief Title

Hyperbaric Oxygen in the Prevention of Radiation Pneumonitis

Research Team

K

Kun Wang

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here